I also emailed DW about this on Monday and he also said to tune into the webinar today.
They highlighted during the webinar the challenges of commissioning the hernia factory on a few occasions as german technicians couldn't get through the border.
Since then they've produced 1300 sheets of Syntrel ready for use in the upcoming animal studies.
I think it's fair to assume if they had delays at the front end with completing the hernia factory then there would have been quite a back log of production to get through in order to have sufficient stock for this clinical trial and this in turn has significantly pushed back the commencement date of this study.
Ann: FY21 Results Presentation, page-83
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 232 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 3934 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |